Jeremiah Simmons
Acute Care · Richland Hills, TXNPI 1932663812
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,561 of the $15,365 with a category attached, or 62.2%. 36 manufacturers reported payments, led by Sanofi at 29.4% of the total. 2025 is the largest year on record at $10,557, 6.8 times the $1,544 reported in 2021. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $36.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$5K
- Inspire Medical Systems, Inc.$3K
- AstraZeneca$2K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$778
- Baxter Healthcare$483
- plus $4K from 30 others
What the payments were for
- Consulting fees$2,52016%
- Travel & lodging$3,09620%
- Food & beverage$9,56162%
- Education$1881%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 35 | $4,519 |
| Inspire Medical Systems, Inc. | 30 | $2,968 |
| AstraZeneca | 51 | $1,825 |
| GSK | 81 | $1,020 |
| Regeneron Healthcare Solutions, Inc. | 38 | $778 |
| Baxter Healthcare | 26 | $483 |
| Verona Pharma, Inc. | 23 | $444 |
| Boehringer Ingelheim | 19 | $418 |
| Insmed, Inc. | 13 | $337 |
| Regeneron | 2 | $293 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $243 |
| Amgen | 20 | $213 |
| Jazz Pharmaceuticals Inc. | 8 | $213 |
| Boston Scientific | 5 | $210 |
| Harmony Biosciences LLC | 7 | $163 |
| Electromed, Inc. | 4 | $147 |
| Mylan Specialty L.p. | 2 | $140 |
| Inogen, Inc. | 8 | $122 |
| United Therapeutics Corporation | 5 | $118 |
| Novartis | 4 | $108 |
| Advanced Respiratory, Inc | 5 | $93 |
| Viatris Specialty LLC | 3 | $65 |
| Actelion Pharmaceuticals US, Inc. | 2 | $63 |
| Philips North America LLC | 3 | $51 |
| Grifols USA, LLC | 2 | $51 |
| Optinose US, Inc. | 2 | $48 |
| Vifor Pharma, Inc. | 2 | $48 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| AbbVie | 1 | $26 |
| Novo Nordisk | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Merck | 1 | $16 |
| Bayer | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Liquidia Technologies, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$2,427
- BREZTRI$778
- FASENRA$654
- TEZSPIRE$583
- AIRSUPRA$463
- DUPIXENT$293
- BEVESPI AEROSPHERE$210
- TAGRISSO$191
- Arikayce$149
- GENERAL PULMONARY$126
- Yupelri$123
- Ohtuvayre$119
- Hillrom - Life 2000 Ventilation System$105
How this compares
$15,365 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 28 | $113,033 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 72 | $77,273 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 53 | $38,585 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 14 | $6,121 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $3,996 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $1,363 |
| Montelukast Sodium | 62 | $567 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $1,020 | $77,27372 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $1,825 | $48,70278 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,323 acute care providers in Texas.
Other acute care in Richland Hills
- Edward VasquezRichland Hills$16K
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Bahia ElkamandSugar Land$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.